Drug intelligence / Profile preview

TSPO siRNA

Development stage
Unknown
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Topical, Ophthalmic, Intrathecal, Intraperitoneal
01

Overview

TSPO siRNA is a small interfering RNA designed to silence the expression of the 18 kDa translocator protein (TSPO), also known as the peripheral benzodiazepine receptor. TSPO is an outer mitochondrial membrane protein primarily involved in cholesterol transport and neurosteroid synthesis. In research settings, TSPO siRNA is utilized as a tool to investigate the physiological role of TSPO in various cellular processes, such as airway smooth muscle (ASM) cell contraction, growth, and migration. By achieving significant knockdown of TSPO expression (typically around 80%), researchers can assess the impact of TSPO deficiency on mitochondrial structural features, membrane potential, and intracellular calcium flux. Studies have indicated that while TSPO knockdown may not significantly alter baseline ASM cell stiffness or histamine-induced contraction, it serves as a critical control for evaluating the specific actions of TSPO ligands.

Other names
translocator protein siRNA18 kDa translocator protein siRNAperipheral benzodiazepine receptor siRNA
02

Targets

TSPO (Translocator Protein (18 kDa))

Beyond the preview

Go deeper on TSPO siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TSPO siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call